News: BNO Bionomics Reports Topline Results In Prevail Phase 2 Study Of BNC210

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Dec 19 (Reuters) - Bionomics Ltd (BNO) :

    • REPORTS TOPLINE RESULTS IN PREVAIL PHASE 2 STUDY OF BNC210 IN SOCIAL ANXIETY DISORDER
    • BNC210 FOR TREATMENT OF SOCIAL ANXIETY DISORDER DID NOT MEET PRIMARY ENDPOINT
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.